# FDA 483 - Rentschler Biopharma Inc. - March 22, 2023

Source: https://www.globalkeysolutions.net/records/483/rentschler-biopharma-inc/f192f328-ac15-4dfa-b0a3-6360dc6ce911

> FDA 483 for Rentschler Biopharma Inc. on March 22, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Rentschler Biopharma Inc.
- Inspection Date: 2023-03-22
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2025-01-17](https://www.globalkeysolutions.net/records/483/rentschler-biopharma-inc/8847176a-aea3-4959-8a3d-192a06e2bec6)
- [483 - 2025-01-17](https://www.globalkeysolutions.net/records/483/rentschler-biopharma-inc/6e35a6df-e275-45c2-80e8-23247e93f05c)
- [EIR - 2019-12-13](https://www.globalkeysolutions.net/records/eir/rentschler-biopharma-inc/3306cffb-7bc4-435a-83a0-112dd6797561)
- [EIR - 2025-01-17](https://www.globalkeysolutions.net/records/eir/rentschler-biopharma-inc/6e73238f-6472-418b-a935-878b9d720dbb)
- [483 - 2025-01-17](https://www.globalkeysolutions.net/records/483/rentschler-biopharma-inc/48057dff-8f68-4a39-b45d-06c255b63593)

## Related Officers

- [Charles Luan-Chia Kuo, Staff Fellow](https://www.globalkeysolutions.net/people/charles-luan-chia-kuo-staff-fellow/038269f6-aa8e-46f1-bb93-a5e1ae277d6e)
- [Wendy Tan, PhD, Microbiologist](https://www.globalkeysolutions.net/people/wendy-tan-phd-microbiologist/24f63b1c-33e5-440c-9853-2a18c141afa3)
- [Yuan-Chia Kuo](https://www.globalkeysolutions.net/people/yuan-chia-kuo/35ef21f6-5de8-4fc7-a319-5d5666a4fb62)
- [Lead  Biologist](https://www.globalkeysolutions.net/people/leiyun-boone/454ce531-ae82-4ae4-9b3d-8e4e8afed127)
- [Leiyun Boone, PhD, Pharmaceutical Scientist](https://www.globalkeysolutions.net/people/leiyun-boone-phd-pharmaceutical-scientist/a048aa86-e6b7-47a0-92e7-8b94b7a4640f)

Company: https://www.globalkeysolutions.net/companies/rentschler-biopharma-inc/5ef7256a-aef2-44ce-a792-80c28829c138

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd